Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
27/08/2025
Negotiations with Microsoft or the restructuring of OpenAI may be delayed until next year. (Financial Times)
Latest
1 m ago
CITIC Securities' recent research report pointed out that the initiation of the revision work of the commercial insurance innovative drug catalog by the National Medical Insurance Administration marks the substantive landing stage of the commercial insurance innovative drug catalog. The medical and health industry is expected to usher in a Davis Double-Clicking valuation system restructuring. It is recommended to continue to pay attention to the three investment themes brought by the development of commercial insurance: innovative drug and equipment; commercial insurance comprehensive service providers; differentiated medical terminals. It is recommended to pay attention to Sipai Health and Meixin Health under Shanghai Pharmaceuticals. CITIC Securities believes that the commercial health insurance payment for innovative drug and equipment is expected to increase from 7.3 billion yuan to 126.2 billion yuan from 2023 to 2030, with a CAGR of 50.3%.
1 m ago
Citic Securities interprets the catalogue of innovative drugs for commercial insurance: recommends focusing on three major investment themes, integrated service providers such as Meixin Health and Sipai Health may benefit.
1 m ago
Juhua Group: Net profit in the first half of 2025 was 2.051 billion yuan, an increase of 146.97% year-on-year.
1 m ago
Hengfeng Paper Industry (600356.SH) released its performance for the first half of the year, with a net profit attributable to the parent company of 94.9367 million yuan, an increase of 69.06% year-on-year.
2 m ago
Sky Technology: Net profit for the first half of 2025 was 2.08 billion yuan, a year-on-year increase of 35.74%.
See all latest
